Expects to continue it’s Strong Growth Momentum with Innovation: Record Date Fixed as Tuesday, 15th October 2024 Mumbai (Maharashtra) [India] October 4: The board of directors of Mumbai-based Vaishali Pharma Ltd (NSE–VAISHALI) has fixed the “Record Date” as Tuesday, 15th October 2024. The Company will Split its Equity Shares, having a nominal/face value of INR […]
Continue Reading
Company’s Board recently approved stock split of 1 Equity share of Rs. 10 face value in to five equity shares of Rs. 2 each Mumbai (Maharashtra) [India], August 29: Board of directors of Mumbai-based Vaishali Pharma Ltd (NSE – VAISHALI) has recommended issue of bonus equity shares in the ratio of 1:1 (1 Bonus share […]
Continue Reading
Mumbai (Maharashtra) [India], December 4: Vaishali Pharma Limited, a one of the leading pharmaceutical company based in Mumbai. Company is engaged in the production and marketing of a diverse range of pharmaceutical products. The company recently received a significant order from the African Continent. This development not only signifies the company’s expanding influence but also underscores its growing global reputation and […]
Continue Reading
Mumbai (Maharashtra) [India], November 10: Vaishali Pharma Limited (NSE – VAISHALI), engaged in production and marketing of a diverse range of pharmaceutical products, announced its unaudited Financial Results for H1 & Q2 FY24. Key Financials at a Glance: H1 FY24: • Total Income at ₹ 26.65 Cr • EBITDA at ₹ 5.62 Cr • EBITDA Margin is 21.11 % • Net Profit at ₹ 3.29 Cr • Net Profit Margin is 12.34% • EPS at ₹ 3.10 Q2 […]
Continue Reading
Mr. Atul Vasani, Managing Director, Vaishali Pharma Mumbai (Maharashtra) [India], March 1: Mumbai based Vaishali Pharma Ltd has received orders worth USD 73.85 million (Approx. Rs. 600 crore) from overseas buyer for purchase of Antibiotics Pharmaceutical products. Company has completed the due diligence with the overseas partners and have discussed various prospects for the long-term […]
Continue Reading